Universitat Pompeu Fabra-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2019

  1. Daratumumab in combination with urelumab to potentiate anti-myeloma activity in lymphocyte-deficient mice reconstituted with human NK cells

    OncoImmunology, Vol. 8, Núm. 7